LYNDSEY LINKE: STARTUP MAKES A SPLASH

LYNDSEY LINKE: STARTUP MAKES A SPLASH

NEW ANTIVIRAL TECHNOLOGY HELPS FIGHT AVIAN FLU
MARY GUIDEN

Lyndsey Linke’s swimming skills took her all the way to the U.S. Olympic Trials while she was an engineering undergrad at Colorado State University. Her latest triumph is land-based: She won CSU’s Collegiate Challenge business pitch competition in April, just two weeks after filing papers to incorporate her company, SiVEC Biotechnologies.

Linke has created a new antiviral technology that can be applied as an aerosol to prevent the spread of avian flu virus in poultry. Avian flu is a huge issue for farmers and government agencies. On a global scale, nearly one-third of the world has been affected by avian flu outbreaks. The estimated revenue loss is $40 billion and rising.

Linke received her master’s degree from CSU in 2005, and landed a job with CSU’s Animal Population Health Institute lab, which conducts research on economically important infectious diseases in animals. She earned a Ph.D. through the Department of Clinical Sciences while working full time and remains on staff as a research scientist.

Beyond the contests, Linke sees the big picture of this novel technology she’s created.

“As a researcher, the impact of what I’ve developed is a big deal,” she said. “From the very beginning, the idea wasn’t just that I would develop something. This has the potential to change the industry, not just in the United States but globally,” she said.

Series Navigation<< LEGACY AT SEA: GRISWOLD FAMILYFIT FOR PRINT: SPAYD NEW PUBLIC EDITOR OF NEW YORK TIMES >>